TY - JOUR
T1 - Correction to
T2 - Therapeutic drug monitoring of oral targeted antineoplastic drugs (European Journal of Clinical Pharmacology, (2021), 77, 4, (441-464), 10.1007/s00228-020-03014-8)
AU - Mueller-Schoell, Anna
AU - Groenland, Stefanie L.
AU - Scherf-Clavel, Oliver
AU - van Dyk, Madelé
AU - Huisinga, Wilhelm
AU - Michelet, Robin
AU - Jaehde, Ulrich
AU - Steeghs, Neeltje
AU - Huitema, Alwin D.R.
AU - Kloft, Charlotte
PY - 2021/4
Y1 - 2021/4
N2 - Due to an error during production, some in-text and most of the in-table citations were not correctly displayed in the original previous online version of the article and have now been corrected. The original article has been corrected.
AB - Due to an error during production, some in-text and most of the in-table citations were not correctly displayed in the original previous online version of the article and have now been corrected. The original article has been corrected.
KW - Targeted antineoplastic drugs
KW - Tyrosine kinase inhibitors
KW - Therapeutic drug monitoring
KW - Oral anticancer drugs
KW - Personalised medicine
UR - http://www.scopus.com/inward/record.url?scp=85097546565&partnerID=8YFLogxK
U2 - 10.1007/s00228-020-03067-9
DO - 10.1007/s00228-020-03067-9
M3 - Comment/debate
AN - SCOPUS:85097546565
VL - 77
SP - 465
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
SN - 0031-6970
IS - 4
ER -